ARTICLE | Clinical News
Natesto regulatory update
February 9, 2015 8:00 AM UTC
Trimel submitted an NDS to Health Canada for Natesto testosterone nasal gel as replacement therapy in men for conditions associated with a deficiency or absence of endogenous testosterone. The bioadhe...